Literature DB >> 23616843

Comparing the effectiveness of computerized adverse drug event monitoring systems to enhance clinical decision support for hospitalized patients.

G N Petratos1, Y Kim, R S Evans, S D Williams, R M Gardner.   

Abstract

OBJECTIVE: Performance of computerized adverse drug event (ADE) monitoring of electronic health records through a prospective ADE Monitor and ICD9-coded clinical text review operating independently and simultaneously on the same patient population for a 10-year period are compared. Requirements are compiled for clinical decision support in pharmacy systems to enhance ADE detection.
METHODS: A large tertiary care facility in Utah, with a history of quality improvement using its advanced hospital information system, was leveraged in this study. ICD9-based review of clinical charts (ICD9 System) was compared quantitatively and qualitatively to computer-assisted pharmacist-verified ADEs (ADE Monitor). The capture-recapture statistical method was applied to the data to determine an estimated prevalence of ADEs.
RESULTS: A total estimated ADE prevalence of 5.53% (13,420/242,599) was calculated, with the ICD9 system identifying 2,604 or 19.4%, and the ADE monitor 3,386 or 25.2% of all estimated ADEs. Both methods commonly identified 4.9% of all estimated ADEs and matched 62.0% of the time, each having its strength in detecting a slightly different domain of ADEs. 70% of the ADE documentation in the clinical notes was found in the discharge summaries.
CONCLUSION: Coupled with spontaneous reporting, computerized methods account for approximately half of all ADEs that can currently be detected. To enhance ADE monitoring and patient safety in a hospitalized setting, pharmacy information systems should incorporate prospective structuring and coding of the text in clinical charts and using that data alongside computer-generated alerts of laboratory results and drug orders. Natural language processing can aid computerized detection by automating the coding, in real-time, of physician text from clinical charts so that decision support rules can be created and applied. New detection strategies and enhancements to existing systems should be researched to enhance the detection of ADEs since approximately half are not currently detected.

Entities:  

Keywords:  Clinical decision support; data collection; error management and prevention; pharmacy information systems; system improvement

Year:  2010        PMID: 23616843      PMCID: PMC3631899          DOI: 10.4338/ACI-2009-11-RA-0009

Source DB:  PubMed          Journal:  Appl Clin Inform        ISSN: 1869-0327            Impact factor:   2.342


  23 in total

1.  Does clinical evidence support ICD-9-CM diagnosis coding of complications?

Authors:  E P McCarthy; L I Iezzoni; R B Davis; R H Palmer; M Cahalane; M B Hamel; K Mukamal; R S Phillips; D T Davies
Journal:  Med Care       Date:  2000-08       Impact factor: 2.983

2.  Development of a computerized adverse drug event monitor.

Authors:  R S Evans; S L Pestotnik; D C Classen; S B Bass; R L Menlove; R M Gardner; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

3.  Capture-recapture methods in surveys of diseases of the nervous system.

Authors:  C N Martyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

4.  The HELP system.

Authors:  T A Pryor; R M Gardner; P D Clayton; H R Warner
Journal:  J Med Syst       Date:  1983-04       Impact factor: 4.460

5.  Identifying hospital admissions due to adverse drug events using a computer-based monitor.

Authors:  A K Jha; G J Kuperman; E Rittenberg; J M Teich; D W Bates
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Mar-Apr       Impact factor: 2.890

6.  Adverse drug events in emergency department patients.

Authors:  John W Hafner; Steven M Belknap; Marc D Squillante; Kay A Bucheit
Journal:  Ann Emerg Med       Date:  2002-03       Impact factor: 5.721

7.  Preventing adverse drug events in hospitalized patients.

Authors:  R S Evans; S L Pestotnik; D C Classen; S D Horn; S B Bass; J P Burke
Journal:  Ann Pharmacother       Date:  1994-04       Impact factor: 3.154

8.  Computerized surveillance of adverse drug events in hospital patients.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

9.  Prevention of adverse drug events through computerized surveillance.

Authors:  R S Evans; S L Pestotnik; D C Classen; S B Bass; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1992

10.  Understanding pharmacist decision making for adverse drug event (ADE) detection.

Authors:  Shobha Phansalkar; Jennifer M Hoffman; John F Hurdle; Vimla L Patel
Journal:  J Eval Clin Pract       Date:  2009-04       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.